Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCT

Background In patients with a glioma, 50–80% will have seizures during their lifetime and half of these will be drug resistant. Seizure risk is increased perioperatively (around the time of surgery) at tumour progression and shortly before death. In seizure-naive patients with glioma undergoing surg...

Cijeli opis

Bibliografski detalji

Glavni autori:	Michael D Jenkinson, Helen Bulbeck, Jade Carruthers, Jacqueline Burns, Sarah Lessels, Richard Dobbie, Rachael Watson, Ciara Gribben, Alasdair G Rooney, Gerard Thompson, Tomos Robinson, Luke Vale, Sara Erridge, Colin Watts, Anthony G Marson, Robin Grant
Format:	Artigo
Jezik:	Inglês
Izdano:	NIHR Journals Library 2026-03-01
Serija:	Health Technology Assessment
Teme:	glioma seizure clinical trial levetiracetam prophylaxis
Online pristup:	https://doi.org/10.3310/GJMJ1815
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!